Co-Amlessa tablets

Riik: Armeenia

keel: inglise

Allikas: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Toote omadused Toote omadused (SPC)
22-10-2020

Toimeaine:

perindopril (perindopril tert-butylamine), amlodipine (amlodipine besilate), indapamide

Saadav alates:

KRKA d.d.

ATC kood:

C09BX01

INN (Rahvusvaheline Nimetus):

perindopril (perindopril tert-butylamine), amlodipine (amlodipine besilate), indapamide

Annus:

4mg+ 10mg+ 1,25mg

Ravimvorm:

tablets

Ühikuid pakis:

(30/3x10/) in blister

Retsepti tüüp:

Prescription

Volitamisolek:

Registered

Loa andmise kuupäev:

2016-07-20

Toote omadused

                                Summary of product characteristics
CONFIDENTIAL
Co-Amlessa tablet 2 mg/5 mg/0.625 mg, 4 mg/5 mg/1.25
mg, 4 mg/10 mg/1.25 mg, 8 mg/5 mg/2.5 mg, 8 mg/10
VOL: 1; P: 68 / 1048
1.3.1
Perindopril+Indapamide+Amlodipine
SPC, Labeling and Package Leaflet
AM
SmPCPIL153367_1
20.07.2020 – Updated: 20.07.2020
Page 1 of 27
1.
NAME OF THE MEDICINAL PRODUCT
Co-Amlessa 2 mg/5 mg/0.625 mg tablets
Co-Amlessa 4 mg/5 mg/1.25 mg tablets
Co-Amlessa 4 mg/10 mg/1.25 mg tablets
Co-Amlessa 8 mg/5 mg/2.5 mg tablets
Co-Amlessa 8 mg/10 mg/2.5 mg tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Co-Amlessa 2 mg/5 mg/0.625 mg tablets
Each tablet
contains 2 mg perindopril tert-butylamine, 5 mg amlodipine (as
besilate) and 0.625 mg
indapamide.
Co-Amlessa 4 mg/5 mg/1.25 mg tablets
Each tablet
contains 4 mg perindopril tert-butylamine, 5 mg amlodipine (as
besilate) and 1.25 mg
indapamide.
Co-Amlessa 4 mg/10 mg/1.25 mg tablets
Each tablet
contains 4 mg perindopril tert-butylamine, 10 mg amlodipine (as
besilate) and 1.25 mg
indapamide.
Co-Amlessa 8 mg/5 mg/2.5 mg tablets
Each tablet contains 8 mg perindopril tert-butylamine, 5 mg amlodipine
(as besilate) and 2.5 mg
indapamide.
Co-Amlessa 8 mg/10 mg/2.5 mg tablets
Each tablet
contains 8 mg perindopril tert-butylamine, 10 mg amlodipine (as
besilate) and 2.5 mg
indapamide.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Co-Amlessa 2 mg/5 mg/0.625 mg tablets: White to almost white, oval,
biconvex tablets scored on one
side. The score line is only to facilitate breaking for ease of
swallowing and not to divide into equal
doses.
Co-Amlessa 4 mg/5 mg/1.25 mg tablets: White to almost white, round,
slightly biconvex tablets with
bevel edges.
Co-Amlessa 4 mg/10 mg/1.25 mg tablets: White to almost white, oval,
biconvex tablets scored on one
side. The tablet can be divided into equal doses.
Co-Amlessa 8 mg/5 mg/2.5 mg tablets: White to almost white, round,
biconvex tablets with bevel
edges.
Co-Amlessa 8 mg/10 mg/2.5 mg tablets: White to almost white, round,
biconvex tablets s
                                
                                Lugege kogu dokumenti
                                
                            

Dokumendid teistes keeltes

Infovoldik Infovoldik vene 22-10-2020

Vaadake dokumentide ajalugu